Joseph Lewis, 10% Owner, Director at Odonate Therapeutics, Inc. (ODT), bought 416,666 shares at $24.00 ($10.0M) on 2017-12-06, disclosed to the SEC on 2017-12-08.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| MRTX | SELL | 2020-10-30 | $154.5M | — | Filing → |
| ODT | BUY | 2020-09-30 | $2.9M | — | Filing → |
| ODT | BUY | 2020-09-09 | $3.4M | — | Filing → |